Leapfrog ordered to remove safety grade for 5 Tenet hospitals / Fierce

fiercehealthcare - A federal judge said a 2024 methodology update that adjusted the weighting of safety measures inputted for nonparticipating hospitals was "deceptive and unfair" under Florida law. Leapfrog plans to appeal, but said it will be making broader changes in rat…

fiercehealthcare - The deal, effective March 3, includes 126 physicians and advanced practitioners, expanding the academic system's primary care capacity.

#healthcare #mergersandacquisitions #corporatetakeover #hospitaloperations #healthcarefinance

COOs’ role gains complexity amid outpatient care shift

38 hrs / beckershospitalreview / Kelly Gooch

Wyoming hospital ‘resisting private equity’ to affiliate with Billings Clinic

2 days / beckershospitalreview / Alan Condon

MUSC Health acquires South Carolina's largest multispecialty practice for $111M

6 days / fiercehealthcare

MUSC Health buys primary care group for $111M

7 days / beckershospitalreview / Erica Cerutti

Monday, March 9, 2026, 12:22 am / permalink 20353 / 4 stories in 2 days

Eli Lilly's new program aims to boost employer coverage of GLP-1s / Endpoints

Shelby Livingston / endpoints - With insurance coverage of weight loss medications stalled, Eli Lilly has developed a program to give employers another way to pay for their workers' GLP-1 treatments. The pharma giant on Thursday announced the launch of ...

#obesity #healthcare #pharmaceuticals #drugpricing #elililly #weightloss #healthcarefinance

GLP-1 medication changes may support long-term weight management

16 hrs / medicalxpress

Wegovy may have highest 'eye stroke' and sight loss risk among semaglutide GLP-1 agonists

17 hrs / medicalxpress

2018 to 2025 saw rise in GLP-1 receptor agonist Rx for bariatric surgery-eligible patients

18 hrs / medicalxpress

Carrum Health teams up with Virta Health on a comprehensive weight loss solution

22 hrs / fiercehealthcare

Ascletis touts GLP-1 quarterly dosing data; Mineralys apnea Phase 2 misses

24 hrs / endpoints / ENDPOINTS

Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males

34 hrs / medicalxpress

Digital nudges help GLP-1 users: Stanford

42 hrs / beckershospitalreview / Giles Bruce

Hims & Hers makes deal with Novo Nordisk as it shifts obesity strategy

46 hrs / fiercehealthcare

10 drugs poised to be global best-sellers in 2030

47 hrs / beckershospitalreview / Paige Twenter

AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China

2 days / endpoints / ENDPOINTS

Amazon Pharmacy expands Zepbound access

2 days / beckershospitalreview / Ella Jeffries

Hims agrees to limit compounding, ending feud with Novo Nordisk

2 days / endpoints / Shelby Livingston

Novo, Hims strike GLP-1 deal after legal feud

2 days / beckershospitalreview / Ella Jeffries

Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?

2 days / medcitynews / Frank Vinluan

Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says

5 days / medcitynews / Marissa Plescia

Eli Lilly's new program aims to boost employer coverage of GLP-1s

5 days / endpoints / Shelby Livingston

Saturday, March 7, 2026, 10:21 pm / permalink 20341 / 16 stories in 3 days

Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient / Fierce

fiercehealthcare - A recent claims data analysis shows the 11% of people with multiple chronic conditions are behind 52% of inpatient admissions and about a third of outpatient visits. Their projected increases and unfavorable payer mix spell trouble for health systems' bot…

#healthcare #publichealth #hospitaloperations #healthcarefinance

11% of US population accounts for 52% of admissions: Vizient

6 days / beckershospitalreview / Paige Twenter

Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient

7 days / fiercehealthcare

Saturday, March 7, 2026, 10:21 pm / permalink 20340 / 2 stories in 3 days

Elizabeth McKenna: New Cancer Grand Challenges Teams Announced / OncoDaily

oncodaily - Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X: “The new Cancer Grand Challenges teams have just been announced! Read about the teams tackling cancer avoidance, mechanisms […]

#healthcare #biotech #drugdevelopment #oncology #healthcarefinance #cancerresearch #researchfunding

Accelerating Cancer Immunotherapy: Parker Institute & ASCO Launch Young Investigator Award

9 hrs / oncodaily

Douglas R. Lowy, MD, FAACR, and John T. Schiller, PhD, FAACR, Honored with the 2026 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research

30 hrs / aacr / Julia DeMalto

Shared patterns of dysregulated gene expression across squamous cell carcinomas unveil predictors for prognosis and drug sensitivity

39 hrs / nature

Hidden metabolism found operating inside the cell nucleus

39 hrs / sciencedaily

Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to Experience Reservoir Decay with Anti-PD1 Therapy

2 days / esmo

Study finds no evidence that prostate cancer drugs interact with anticoagulants to increase bleeding, clotting risks

2 days / medicalxpress

UK cancer death rates down to their lowest level on record

2 days / cancerresearchuk / Tim Gunn

OncoGrants Weekly: Top 10 OncoGrants to Apply for in 2026: Deadlines from March to June

2 days / oncodaily

A multicenter retrospective study of plasma d‑dimer levels for evaluating treatment response in multiple myeloma

2 days / nature

Prescription‑dose stratification improves deep learning‑based VMAT dose prediction in locally advanced NSCLC

2 days / nature

Gian Paolo Andreoletti: What If Cancer Originated Primarily From Systemic Metabolism?

2 days / oncodaily

Stephen Williams: Proud to Serve as Global PI for SunRISe-2 Trial

2 days / oncodaily

Binay Shah: 2nd Annual Binaytara Oklahoma Thoracic Oncology Conference

2 days / oncodaily

Sheraz Azhar: OncsCare Shortlisted for Medilink Midlands Business Awards 2026

2 days / oncodaily

Anton Safonov: Germline-Somatic Interactions Predict Treatment Resistance in Breast Cancer

2 days / oncodaily

Patrick Hwu: Why Some Cancer Cells Evade the Immune System During Early Spread

2 days / oncodaily

Vivek Subbiah: Commentary on Australia’s MoST Program

2 days / oncodaily

David C. Michael: How Epigenetics Shapes Cancer Beyond DNA Mutations

2 days / oncodaily

Samuel Stevens: Australian Oncologist Perspectives on Time Toxicity

2 days / oncodaily

International Women’s Day Highlights 2026: Honoring Women in Oncology

2 days / oncodaily

Ruben Mesa: Clinical and Translational Research Award Winners at Myeloid Malignancy Workshop

2 days / oncodaily

Joanna Metzner-Sadurski Highlights Key Takeaways from ASCO CoP Health Policy Webinar

2 days / oncodaily

ESTRO Issues New Guidance on IMRT and IGRT for Rectal Cancer – Radiotherapy and Oncology

2 days / oncodaily

Jeff Hanna Appointed Co-opted Board Member at UK Oncology Nursing Society

2 days / oncodaily

Emily Touloukian Joins Leaders Addressing Access to Cancer Care at ASCO Council Meeting

2 days / oncodaily

Jia Jenny Liu Shares Takeaways from APOS 2026 on the Future of Precision Oncology

2 days / oncodaily

Arturo LoAIza-Bonilla: AI in Lung Cancer Care at New York Lung Cancer Foundation Summit

2 days / oncodaily

Jemma Longley Returns to Teach Immunotherapy at The Institute of Cancer Research

2 days / oncodaily

Rahul Gosain Reviews Treatment Strategies for Triple Negative Breast Cancer

2 days / oncodaily

Ursula Catena Presents Study on Fertility-Preserving Treatment in Endometrial Disease

2 days / oncodaily

Ola Khorshid Leads Discussion on Global Health and Lung Cancer Disparities

2 days / oncodaily

Giuseppe Curigliano: New Therapies and the Role of Oncology Congresses – The Breast Friends Podcast

2 days / oncodaily

Countdown to the GCOS26 Champions League – International Cardio-Oncology Society

2 days / oncodaily

Alexandra Pons Riverola Shares Key Insights on Collaboration Between Cardiologists and Oncologists

2 days / oncodaily

Felipe Couñago: Global Assessment of Radiotherapy Access Gap and Future Needs

2 days / oncodaily

Rishabh Jain Explores RB1 Loss as a Driver of CDK4/6 Resistance in BRCA2 Breast Cancer

2 days / oncodaily

Wafik S. El-Deiry: Discussed Breast Cancer Stem-Like Cells at MIT Seminar

2 days / oncodaily

Daniel Stover: Multidisciplinary Breast Cancer Symposium at UChicago

2 days / oncodaily

Christopher Jackson: Defending Champion Title in the Oncologists’ Fitness Challenge

2 days / oncodaily

Preventing breast cancer resistance to CDK4/6 inhibitors using genomic findings

3 days / medicalxpress

Kim Curseen Named AAHPM’s Board President for 2026–2027 – AAHPM

3 days / oncodaily

Enrique Soto Pérez de Celis and the Future of Supportive Oncology at MASCC

3 days / oncodaily

Oncology This Two Weeks: OncoDaily Weekly Feb 23 – March 8, 2026

3 days / oncodaily

New Trial Seeks to Improve Sharing of Genetic Colorectal Cancer Risks – Alliance for Clinical Trials in Oncology

3 days / oncodaily

Sendurai Mani: A Successful Launch of the Hallmarks of Cancer Virtual Seminar Series

3 days / oncodaily

What pet cats can tell us about human cancer

3 days / theconversation / Geoffrey Wood, Professor, Co-Director, Institute for Comparative Cancer Investigation, University of

Tracey O’Brien: Faces of Some of the Extraordinary Women Helping to Prevent and Treat Cancer in NSW

3 days / oncodaily

Benny Johnson is Now The Executive Medical Director at Agenus

3 days / oncodaily

Jasmine Kamboj: How Showing Up And Engaging Is The First Step Of Leadership?

3 days / oncodaily

Angela Lamarca Celebrates ENETS Centre of Excellence Recognition for Fundación Jiménez Díaz

3 days / oncodaily

Rihab Melliti: An Advanced Course from ESMO for Patients With Advanced HR+/HER2− Breast Cancer

3 days / oncodaily

Bishal Gyawali Promotes ESMO Leadership Award as Pathway to Global Oncology Training

3 days / oncodaily

Giulia Madamombe: Presenting a Work at the 24th BTOG Annual Conference

3 days / oncodaily

International Women’s Day 2026: Championing women in cancer research

3 days / cancerresearchuk / Sophie Wedekind

Targeting erythroid progenitor cell metabolism to enhance cancer immunotherapy

3 days / nature

Performance of breast cancer risk prediction algorithms across mammography systems in the UK screening programme

3 days / nature

Alicia Zhou: How Open Data Could Accelerate Immunotherapy Discoveries

3 days / oncodaily

Lorenzo de la Rica: Cancer Grand Challenges Announces Five New Global Teams with £100M Investment

3 days / oncodaily

Yelena Janjigian and Norah Lewin Join NBC’s Saturday TODAY to Discuss Cycle for Survival’s 20th Anniversary

3 days / oncodaily

Smita Krishnaswamy: Proud to be Part of the Newly Funded CRUK Cancer Grand Challenge Team

3 days / oncodaily

Elizabeth C. Miller: Raised Over $416K for Pediatric Cancer Research

3 days / oncodaily

Pediatric Cancer Research Foundation: Recognizing 2026 Grant Recipients Advancing Childhood Cancer Research

3 days / oncodaily

Global Partners Unite to Fund High-Risk, High-Reward Cancer Science – Cancer Grand Challenges

5 days / oncodaily

Elizabeth McKenna: New Cancer Grand Challenges Teams Announced

5 days / oncodaily

Manju George: Joining the REWIRE CAN Team at Cancer Grand Challenges 2026

5 days / oncodaily

Congratulations to Karuna Ganesh and Team for Receiving the Cancer Grand Challenges Grant – MSKCC

6 days / oncodaily

The new Cancer Grand Challenges teams pushing the frontiers of science

7 days / cancerresearchuk / Tim Gunn

Saturday, March 7, 2026, 11:22 am / permalink 20326 / 67 stories in 3 days

CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance / OncoDaily

oncodaily - ALRCaN presents “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS” with Dr. Valentín Ortiz-Maldonado. “Dear friends and colleagues, […]

#healthcare #publichealth #governmentpolicy #healthcarefinance #infectiousdisease

'I'm still haunted that he died alone': The last voices of the Covid inquiry

5 days / bbc

CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance

5 days / oncodaily

Covid inquiry chair defends £200m cost and four-year process on final day

5 days / bbc

Covid inquiry chair defends £200m cost and four-year process on final day

5 days / bbc

Saturday, March 7, 2026, 2:22 am / permalink 20317 / 4 stories in 4 days

Telehealth growth hasn’t increased rural behavioral healthcare access: Study / Beckers

Giles Bruce / beckershospitalreview - The rise in telemedicine over the past several years hasn’t translated to more behavioral healthcare access in rural areas, according to a March 5 study in JAMA Network Open. Researchers from Boston-based Harvard Medical School and Providence, R.I.-based …

#healthcare #publichealth #governmentpolicy #digitalhealth #behavioralhealth #healthcarefinance

Why UHS Is Acquiring Talkspace for $835M

17 hrs / medcitynews / Marissa Plescia

Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic

2 days / medicalxpress

Virtual-First Care Shouldn’t Spark an “A-Ha” Moment Anymore

3 days / medcitynews / Michael Dalton

Telehealth growth hasn’t increased rural behavioral healthcare access: Study

4 days / beckershospitalreview / Giles Bruce

Study finds telemedicine surge barely changed rural mental health access

6 days / medicalxpress

Saturday, March 7, 2026, 1:22 am / permalink 20316 / 5 stories in 4 days

New FDA bonus pilot to address 'workforce challenges' / Endpoints

Max Bayer / endpoints - A new bonus pilot program meant to reward fast-working FDA reviewers will be funded in part by money from industry user fees, the first details on how Commissioner Marty Makary plans to finance the incentive ...

#healthcare #pharmaceuticals #governmentpolicy #biotech #drugdevelopment #fda #healthcarefinance

New FDA bonus pilot to address 'workforce challenges'

5 days / endpoints / Max Bayer

FDA to offer cash bonuses for faster drug reviews

8 days / medicalxpress

Saturday, March 7, 2026, 12:23 am / permalink 20312 / 2 stories in 4 days

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive

Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #healthcarefinance

It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?

2 days / medcitynews / Marissa Plescia

FTC seeing 'progress' in discussions with Optum, Caremark in insulin case

5 days / fiercehealthcare

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC

6 days / healthcaredive / Rebecca Pifer Parduhn

Saturday, March 7, 2026, 12:23 am / permalink 20308 / 3 stories in 4 days

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity

Frank Vinluan / medcitynews - Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna’s full financial payout to the companies is reache…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #healthcarefinance #infectiousdisease

Hung Trinh: Moderna Reaches $2.25B Settlement in mRNA Vaccine Patent Dispute

4 days / oncodaily

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology

6 days / medcitynews / Frank Vinluan

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

7 days / endpoints / Nicole DeFeudis

Saturday, March 7, 2026, 12:22 am / permalink 20307 / 3 stories in 4 days

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity

Frank Vinluan / medcitynews - Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in chi…

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment #oncology #healthcarefinance

Agreement with Day One Biopharmaceuticals to Expand Glioma Portfolio – Servier

3 days / oncodaily

Servier: A Caregiver’s Powerful Story on Rare Disease

4 days / oncodaily

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma

4 days / medcitynews / Frank Vinluan

Servier to buy Day One for $2.5B, gaining rare oncology medicines

5 days / endpoints / Kyle LaHucik

Saturday, March 7, 2026, 12:22 am / permalink 20306 / 4 stories in 4 days

Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive

Emily Olsen / healthcaredive - The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #hospitaloperations #healthcarefinance

Judge dismisses Pennsylvania hospitals’ lawsuit over CVS’ 340B practices

4 days / beckershospitalreview / Ella Jeffries

Hospitals urge regulators to halt drugmakers’ expanded 340B data policies

5 days / healthcaredive / Emily Olsen

Higher heat stress leads to more cardiac ICU admissions, researchers find

6 days / medicalxpress

Hospitals decry drugmakers' expanded claims reporting policies for 340B

6 days / fiercehealthcare

Friday, March 6, 2026, 12:23 pm / permalink 20277 / 4 stories in 4 days

AI blood test finds silent liver disease years before symptoms / Science Daily Cancer

sciencedaily - Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wid…

#healthcare #publichealth #biotech #digitalhealth #medicaldevices #healthcarefinance

Ali Choukair Presents a 360° Approach to Metabolic Liver Disease – Emirates Digestive Diseases Week

4 days / oncodaily

ImmunoXXL Phase 2 Study: Liver Transplantation After Atezolizumab–Bevacizumab Downstaging in Advanced HCC

4 days / oncodaily

AI blood test finds silent liver disease years before symptoms

5 days / sciencedaily

AI-based liquid biopsy may detect liver fibrosis, cirrhosis and chronic disease signals

6 days / medicalxpress

Cell-free DNA fragmentomes for noninvasive detection of liver cirrhosis and other diseases

7 days / science / Akshaya V. Annapragada, Zachariah H. Foda, Hope Orjuela, Carter Norton, Shashikant Koul, Noushin Nik

Friday, March 6, 2026, 1:22 am / permalink 20251 / 5 stories in 5 days

Amazon launches Amazon Connect Health / Beckers

Naomi Diaz / beckershospitalreview - Amazon Web Services has launched Amazon Connect Health, an artificial intelligence tool designed to automate administrative tasks for health systems and improve patient access to care. Here are six things to know about Amazon Connect Health: Amazon Connec…

#healthcare #digitalhealth #hospitaloperations #healthcarefinance

Richard Dirven Calls for Responsible Integration of AI in Precision Oncology Care

4 days / oncodaily

CVS, Humana & More Are Turning to Google’s AI Models

4 days / medcitynews / Katie Adams

Highmark Health generates $28M in value with Google AI

4 days / beckershospitalreview / Giles Bruce

Privacy Expectations in Consumer AI Tools: How Patient Use of ChatGPT Health and Claude Differs From HIPAA-Regulated Care

5 days / medcitynews / Nirmal Vemanna

How to use AI tools to support our wellbeing in safe and simple ways

5 days / bbc

Future of Health Tech: From Structured Data to Scalable AI [Video]

5 days / medcitynews / wlim

Salesforce partners with HealthEx, Verily and Viz.ai to build out healthcare AI agents

5 days / fiercehealthcare

Optum expands Microsoft collaboration to add AI to claims platform

5 days / beckershospitalreview / Naomi Diaz

4 health system leaders join initiative to improve patient safety with AI

5 days / beckershospitalreview / Giles Bruce

AI Startups Are Tying Fees to Completed Tasks. Will Hospitals Buy In?

5 days / medcitynews / Katie Adams

Microsoft unveils new Dragon Copilot AI capabilities for clinicians

5 days / beckershospitalreview / Naomi Diaz

Optum teams with Microsoft to expand AI-powered claims platform

5 days / fiercehealthcare

Waystar expanding Google Cloud collaboration

5 days / beckershospitalreview / Andrew Cass

The algorithm will see you now? Patients say not without a doctor nearby

5 days / medicalxpress

Amazon launches Amazon Connect Health

6 days / beckershospitalreview / Naomi Diaz

Amazon launches suite of healthcare AI agents

6 days / healthcaredive / Emily Olsen

When Artificial Intelligence Starts Rewriting Reality

6 days / thehealthcareblog / matthew holt

AWS offers agentic AI solution to tackle scheduling, ambient note-taking and medical coding

6 days / fiercehealthcare

Thursday, March 5, 2026, 11:23 am / permalink 20205 / 18 stories in 5 days

Novo Nordisk inks $2.1B oral obesity drug deal / Beckers

Ella Jeffries / beckershospitalreview - Novo Nordisk has partnered with Vivtex Corp. to develop next-generation oral biologic medicines for obesity, diabetes and related conditions. Under the agreement, Vivtex will license its proprietary oral drug-delivery technologies to Novo Nordisk and is e…

#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #biotech #drugdevelopment #healthcarefinance

Pfizer gets obesity drug approval in China shortly after buying local rights

5 days / endpoints / Elizabeth Cairns

Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity

5 days / medicalxpress

Roche partner Zealand posts Phase 2 data for amylin obesity drug

5 days / endpoints / Kyle LaHucik

Novo Nordisk details Irish expansion; EuroAPI’s challenges continue

6 days / endpoints / Anna Brown

What to know about how GLP-1 medications might fight addiction

6 days / medicalxpress

Twenty percent of eligible youth prescribed GLP-1 receptor agonists

6 days / medicalxpress

GLP-1 medications get at the heart of addiction, study finds

6 days / medicalxpress

Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last

6 days / medicalxpress

Eli Lilly launches its direct-to-employer platform for obesity drugs

6 days / fiercehealthcare

Most Patients Keep Weight Off With Fewer GLP-1 Shots, Study Finds

6 days / nytimes / Roni Caryn Rabin

AHA urges HHS to block Novo Nordisk’s 340B data demand

6 days / beckershospitalreview / Paige Twenter

FDA sends Novo Nordisk 2nd warning over GLP-1 ads

6 days / beckershospitalreview / Erica Cerutti

How gut bacteria and diet can reprogram fat to burn more energy

7 days / medicalxpress

No more weekly injections? How lettuce cells could deliver GLP-1 pills

7 days / medicalxpress

GLP-1 weight-loss drugs comparably effective across age, race and starting weight

7 days / medicalxpress

FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters

7 days / fiercehealthcare

FDA warns 30 telehealth firms over compounded GLP-1 claims

7 days / beckershospitalreview / Ella Jeffries

Hims partner Strive Pharmacy will reintroduce GLP-1 pill pulled from market

8 days / endpoints / Shelby Livingston

Novo Nordisk inks $2.1B oral obesity drug deal

9 days / beckershospitalreview / Ella Jeffries

Novo Nordisk Commits Up to $2B to Drug Delivery Startup Vivtex for R&D of Oral Metabolic Meds

13 days / medcitynews / Frank Vinluan

Novo Nordisk teams with Langer-founded biotech for oral obesity drugs

14 days / endpoints / Kyle LaHucik

Tuesday, March 3, 2026, 1:22 am / permalink 20039 / 21 stories in 8 days

Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

Lei Lei Wu / endpoints - Atrium Therapeutics launched Friday morning as Novartis closed the $12 billion deal to buy Avidity Biosciences and its RNA muscle therapies. The spinout will take on Avidity’s early-stage programs for genetic cardiomyopathies — heart muscle diseases ...

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #corporatetakeover #drugdevelopment #healthcarefinance

Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions

10 days / medcitynews / Frank Vinluan

Novartis closes Avidity deal as rare heart disease spinout launches

12 days / endpoints / Lei Lei Wu

Monday, March 2, 2026, 12:23 am / permalink 19968 / 2 stories in 9 days

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity

Katie Adams / medcitynews - About 31,000 Kaiser Permanente workers ended a four-week strike after reaching a tentative agreement that includes measures to address chronic understaffing and wage increases. The full contract has not yet been ratified.The post After 4-Week Strike, Kais…

#healthcare #publichealth #hospitaloperations #healthcarefinance

The Kaiser Settlement Should End the Guesswork in Medicare Advantage Oversight

6 days / medcitynews / David Lareau

2,400 Kaiser mental health workers to hold 1-day strike

6 days / beckershospitalreview / Kelly Gooch

Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer

9 days / beckershospitalreview / Vedant Bhosale

Four Proven Approaches to Stabilizing Clinical Operations

9 days / beckershospitalreview / Vedant Bhosale

Clinician Engagement: The Operating Lever Behind Margin and Throughput

9 days / beckershospitalreview / Vedant Bhosale

Work environment, moral resilience help nurses prevent moral injury

9 days / medicalxpress

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay

13 days / medcitynews / Katie Adams

31,000 Kaiser workers end strike; mental health clinicians back walkout: 6 notes

15 days / beckershospitalreview / Kelly Gooch

Saturday, February 28, 2026, 12:22 pm / permalink 19945 / 8 stories in 10 days

Merck Splits Oncology Business Unit as Keytruda Patent Expiry Nears / OncoDaily

oncodaily - On February 23, 2026, Merck announced a reorganization of its Human Health structure into two business units: an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. […]

#healthcare #pharmaceuticals #biotech #drugdevelopment #oncology #healthcarefinance

Merck KGaA drops two cancer trials on assets from SpringWorks deal

6 days / endpoints / Reynald Castaneda

No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with Second-Line Treatment in Patients with HR-positive, HER2-negative ABC

8 days / esmo

Cancer Research UK partners with the Royal College of Surgeons of England to help people with rectal cancer avoid unnecessary surgery

8 days / cancerresearchuk / Krishna Sharma

A domain-adaptive deep contrastive network for magnetic resonance imaging-driven bladder cancer classification

8 days / nature

Multicenter ex vivo evaluation of an α-mannosidase–targeted fluorescent probe for intraoperative margin assessment in breast cancer

8 days / nature

Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123

8 days / nature

Merck looks to expand Welireg label following combo readouts with Keytruda, Lenvima

11 days / endpoints / Nicole DeFeudis

Merck Splits Oncology Business Unit as Keytruda Patent Expiry Nears

12 days / oncodaily

Merck reorganizes; Blackstone to fund trials for J&J drug

16 days / endpoints / ENDPOINTS

Saturday, February 28, 2026, 3:22 am / permalink 19937 / 9 stories in 11 days

Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model / Fierce

fiercehealthcare - Teladoc Health reported better-than-expected fourth quarter financial results with both revenue and earnings exceeding analysts' expectations, driving a 15% jump in the company's stock Thursday.

#healthcare #governmentpolicy #digitalhealth #healthcarefinance

Why Telehealth Skills Belong at the Core of Clinical Education

10 days / beckershospitalreview / Nikhil Gaikwad

Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model

12 days / fiercehealthcare

Teladoc projects lower integrated care membership amid ACA subsidy lapse

12 days / healthcaredive / Emily Olsen

Saturday, February 28, 2026, 3:22 am / permalink 19936 / 3 stories in 11 days

CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health / Fierce

fiercehealthcare - Elevance Health Chief Financial Officer Mark Kaye will grow his list of duties to include oversight of Carelon, the company announced Thursday.

#healthcare #digitalhealth #behavioralhealth #healthcarefinance

CMS threatens Elevance with Medicare Advantage sanctions

8 days / healthcaredive / Rebecca Pifer Parduhn

CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans

8 days / fiercehealthcare

CMS to suspend enrollment into Elevance’s Medicare Advantage plans

9 days / beckershospitalreview / Elizabeth Casolo

How Leading Health Systems Are Mastering the Next Capacity Surge

9 days / beckershospitalreview / Vedant Bhosale

Elevance shuffles C-suite as top Carelon exec departs

12 days / healthcaredive / Rebecca Pifer Parduhn

CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health

12 days / fiercehealthcare

Saturday, February 28, 2026, 2:21 am / permalink 19934 / 6 stories in 11 days

Tag Directory / HEALTHCAREFINANCE showing 1–20 of 23

Leapfrog ordered to remove safety grade for 5 Tenet hospitals / Fierce

MUSC Health acquires South Carolina's largest multispecialty practice for $111M / Fierce

Eli Lilly's new program aims to boost employer coverage of GLP-1s / Endpoints

Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient / Fierce

Elizabeth McKenna: New Cancer Grand Challenges Teams Announced / OncoDaily

CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance / OncoDaily

Telehealth growth hasn’t increased rural behavioral healthcare access: Study / Beckers

New FDA bonus pilot to address 'workforce challenges' / Endpoints

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity

Hospitals urge regulators to halt drugmakers’ expanded 340B data policies / Healthcare Dive

AI blood test finds silent liver disease years before symptoms / Science Daily Cancer

Amazon launches Amazon Connect Health / Beckers

Novo Nordisk inks $2.1B oral obesity drug deal / Beckers

Novartis closes Avidity deal as rare heart disease spinout launches / Endpoints

After 4-Week Strike, Kaiser Permanente Workers Score Tentative Win on Staffing & Pay / MedCity

Merck Splits Oncology Business Unit as Keytruda Patent Expiry Nears / OncoDaily

Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model / Fierce

CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health / Fierce

HEALTHCAREFINANCE Heatmap

More Top Stories...

FDA refuses to review Moderna mRNA flu vaccine application

FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

CMS proposes sweeping changes to ACA marketplace plan rules

Tenet forecasts major ACA exchange enrollment drop and financial hit

City of Hope promotes Nisha Morris to senior marketing chief